Boncha Bio

📍 Taipei, Taiwan🗓 Founded 2015👥 9 employees💰 Last funded Sep 2022
Boncha Bio is a pioneering candyceutical maker looking to revolutionize enjoyable preventive medicine by ending the trade-offs between taste and effectiveness. Boncha Bio began with a challenge the nutrition industry thought unsolvable: Turn supplements into candy form yet retaining their effectiveness – so that millions of people stop choking on pills and skipping the meds they need. Candy manufacturing is the perfect process to destroy nutraceutical ingredients. However, our team overcame it by developing an entirely new, patented technology platform to design and manufacture “candyceuticals.” Using advanced manufacturing and nanotechnology, we produce confections that pack the highest dose and bioavailability in the world. Now pharma and nutraceutical companies worldwide are leveraging our platform (NutrientDeliveryOptimizer®. A mouthful, we know) to give their users supplements that are both effective and delicious. Five major features of BonchaBios candyceutical supplement: 1) Symptomatic formula design for each user’s nutritional need 2) High nutrient dose in ONE candy pill 3) High bio-activity retained during manufacturing 4) User-friendly dosage form 5) High bioavailability achieved during absorption We aim to help everyone to get their nutrition with ease without any difficulty.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2015
Founded
Investor geography1 country
Taiwan
1
Frequently asked questions
Who invested in Boncha Bio?
Boncha Bio has 1 investor on record on gritt.io and 1 late-stage investors.
When did Boncha Bio last raise funding?
The most recent investment in Boncha Bio recorded on gritt.io was in September 2022.
When was Boncha Bio founded?
Boncha Bio was founded in 2015.
What industry is Boncha Bio in?
Boncha Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Boncha Bio based?
Boncha Bio is headquartered in Taipei, Taiwan.